Phase 2 study of ibrutinib in classic and variant hairy cell leukemia.
Rogers KA, Andritsos LA, Wei L, McLaughlin EM, Ruppert AS, Anghelina M, Blachly JS, Call T, Chihara D, Dauki A, Guo L, Ivy SP, James LR, Jones D, Kreitman RJ, Lozanski G, Lucas DM, Ngankeu A, Phelps M, Ravandi F, Schiffer CA, Carson WE, Jones JA, Grever MR.
Rogers KA, et al. Among authors: mclaughlin em.
Blood. 2021 Jun 24;137(25):3473-3483. doi: 10.1182/blood.2020009688.
Blood. 2021.
PMID: 33754642
Free PMC article.
Clinical Trial.